Monitor FDA, EMA, CDSCO regulatory changes and guidance globally with real-time alerts and compliance intelligence
Our Regulatory Intelligence service provides comprehensive monitoring of global regulatory authorities including FDA, EMA, CDSCO, PMDA, and more. We deliver real-time alerts on regulatory changes, guidance updates, and compliance requirements that impact pharmaceutical operations.
Stay ahead of regulatory developments with AI-powered analysis that identifies relevant changes, assesses impact on your portfolio, and provides actionable compliance recommendations.
We continuously monitor 12+ major regulatory authorities worldwide, tracking guidance documents, approval decisions, and policy changes.
Machine learning algorithms filter regulatory updates by therapeutic area, indication, and company relevance to eliminate noise.
We assess the potential impact of regulatory changes on your portfolio and provide strategic recommendations.
Optimize regulatory pathways and submission strategies based on precedent and guidance analysis.
Ensure ongoing compliance with evolving regulatory requirements across global markets.
Anticipate regulatory hurdles and plan market entry strategies with regulatory intelligence.
Identify regulatory risks early and develop mitigation strategies for pipeline assets.
Big Pharma Client • 2024
Provided comprehensive regulatory intelligence for global oncology asset launch, identifying key regulatory requirements and optimizing submission strategies across 8 markets.
Biotech Client • 2024
Identified optimal regulatory pathway for rare disease therapy, securing orphan drug designation and accelerated review approval.